Cronos Group Inc Stock News

Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing and favorable side of passing federal reform for cannabis is being discussed by top politicians. In recent talks, President Donald Trump voiced his stance on cannabis and how it should be legalized u...

Cannabis stocks rallied today over news of possible rescheduling by the Trump administration. Even though Cronos Group Inc. does not have a U.S. entry strategy, its stock price was up 15% on the news. Cronos reported improved financial performance last Thursday with higher revenues and improved international sales.

Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a Schedule I drug, along with heroin and cocaine, to Schedule III.

Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth and Tilray Brands both saw surges of over 12% on Monday.

Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the industry, one investing chief said.

Cronos Group Inc. (NASDAQ:CRON ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Anna Shlimak - Chief Financial Officer Harrison Aaron - Corporate Participant Michael Ryan Gorenstein - President, CEO & Chairman Operator Good morning. My name is Stephen, and I will be your conference operator today.

Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS ® retained its position as the number one cannabis brand in Israel 1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:...

Canadian cannabis stocks are gaining momentum this week as the U.S. cannabis market continues to expand. Legal sales in the U.S. are projected to reach nearly $45 billion in 2025. Economic impact is expected to grow even larger, fueling jobs and tax revenue. Currently, adult-use cannabis is legal in over 20 states, while medical programs operate in many more. Recent headlines show renewed inter...